X
XBIO
Xenetic Biosciences Inc
3.200
+0.045+1.43%Pre Market: 3.100 -0.100 -3.13%04:05 04/08 EDT
OPEN/PREV CLOSE3.100/3.155
TODAY RANGE2.990-3.220
VOL134
MARKET CAP7.33M
52 WEEK RANGE1.900-13.93
AVG VOL (3M)25.20K
% TURNOVER1.18%
TURNOVER0
P/E (TTM)-2.0311
% RANGE6.65%
EPS(TTM)-1.5755
P/E(FORWARD)-0.9639
P/B0.9913
BVPS3.228
DIVIDEND--
P/S2.463
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.58M
SHARES OUTSTANDING2.29M
NEXT EARNINGS05/11-05/15
FREE FLOAT2.06M
LOT SIZE1
EX-DATE05/15/2023
News
Press Releases
Financial Reports
Profile
Seeking Alpha·03/13 19:26
Xenetic Biosciences reports FY results
Reuters·03/12 21:04
Xenetic Biosciences FY2025 net loss narrows 32% to USD 2.68 million
Benzinga·01/27 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·01/09 22:15
Xenetic Biosciences faces ongoing delays in annual meeting
Benzinga·12/29/2025 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·12/11/2025 22:29
Xenetic Biosciences Adjourns 2025 Annual Meeting
Benzinga·11/19/2025 21:07
12 Health Care Stocks Moving In Wednesday's After-Market Session
TipRanks·11/19/2025 13:55
Xenetic extends R&D collaboration with The Scripps Research Institute
Seeking Alpha·11/13/2025 15:00
Xenetic Biosciences reports Q3 results
Reuters·11/13/2025 13:53
Xenetic Biosciences Q3 revenue up 67.2% on royalty gains
Benzinga·11/13/2025 13:49
Xenetic Biosciences Q3 EPS $(0.33) Beats $(0.49) Estimate, Sales $1.027M Beat $630.000K Estimate
Reuters·11/13/2025 13:46
Xenetic Biosciences reports third quarter revenue of $1.0 million
Same Industry
Name/Symbol
Change%
Price